Scientific reports Łaniewski Paweł, Features of the cervicovaginal microenvironment drive cancer biomarker signatures in patients across cervical carcinogenesis 9:1, p. 7333 - 7333 2019
Journal of Lower Genital Tract Disease Eakin C., Cervical cancer screening beliefs and prevalence of LSIL/HSIL among a University-Based Population in Cameroon 22:4 2018
Journal of the National Cancer Institute Greenspan D., Re: Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test 107:1 2015
Gynecologic oncology Garcia F. A. R., Results of a phase II randomized, double-blind, placebo-controlled trial of Polyphenon e in women with persistent high-risk HPV infection and low-grade cervical intraepithelial neoplasia 132:2 2014
Journal of Lower Genital Tract Disease Davey D. D., Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion: Review of ancillary testing modalities and implications for follow-up 14:3 2010
Obstetrics and gynecology Greenspan D. L., Compliance after loop electrosurgical excision procedure or cold knife cone biopsy 110:3 2007
Journal of Lower Genital Tract Disease Ferris D. G., Initiating the American Society for Colposcopy and Cervical Pathology Humanitarian Program: Peru 2005 10:1 2006
Journal of Lower Genital Tract Disease Greenspan D. L., Endometrial cells in cervical cytology: Review of cytological features and clinical assessment 10:2 2006
CME Journal of Gynecologic Oncology Hibner M., Ovarian metastases from the biliary tract, pancreas and liver carcinomas 9:2 2004
Clinical Cancer Research Connolly D. C., Loss of Fhit expression in invasive cervical carcinomas and intraepithelial lesions associated with invasive disease 6:9 2000
Prostate Weinstein M. H., Diagnoses rendered on prostate needle biopsy in community hospitals 35:1 1998
International Journal of Gynecological Cancer Lax S. F., Mesenteric and mesocolic lymph node metastases from ovarian carcinoma: A clinicopathological analysis 8:2 1998
Human pathology Vu K., Cellular proliferation, estrogen receptor, progesterone receptor, and bcl-2 expression in GnRH agonist-treated uterine leiomyomas 29:4 1998
Cancer research Greenspan D. L., Loss of FHIT expression in cervical carcinoma cell lines and primary tumors 57:21 1997